13 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33359484 | Albumin-binding prodrugs via reversible iminoboronate forming nanoparticles for cancer drug delivery. | 2021 Feb 10 | 1 |
2 | 29369435 | Design of Protein-Coated Carbon Nanotubes Loaded with Hydrophobic Drugs through Sacrificial Templating of Mesoporous Silica Shells. | 2018 Mar 26 | 2 |
3 | 30338760 | The impact of oxidative stress on binding of drugs with plasma proteins studied by fluorescence anisotropy methods. | 2018 Sep | 2 |
4 | 26309154 | Biophysical and molecular docking insight into interaction mechanism and thermal stability of human serum albumin isoforms with a semi-synthetic water-soluble camptothecin analog irinotecan hydrochloride. | 2016 Jul | 2 |
5 | 27008798 | INTERACTION OF CAMPTOTHECIN WITH HUMAN SERUM ALBUMIN DETERMINED BY FLUORESCENCE ANISOTROPY SPECTROSCOPY. | 2016 Jan-Feb | 1 |
6 | 23791639 | Kinetic and thermodynamic studies of 9-aminocamptothecin hydrolysis at physiological pH in the presence of human serum albumin. | 2013 Aug 16 | 1 |
7 | 22051412 | Binding interactions of water-soluble camptothecin derivatives with bovine serum albumin. | 2012 Feb | 2 |
8 | 21698776 | Camptothecin and thiocamptothecin: the role of sulfur in shifting the hydrolysis equilibrium towards the closed lactone form. | 2011 Sep 5 | 1 |
9 | 16983566 | Effect of pH and human serum albumin on the cytotoxicity of a glucuronide prodrug of 9-aminocamptothecin. | 2007 Jun | 1 |
10 | 17896941 | Hydroxycamptothecin deactivation rates and binding to model membranes and HSA determined by fluorescence spectra analysis. | 2007 Jul | 1 |
11 | 17896945 | Determination of hydroxycamptothecin affinities to albumin and membranes by steady-state fluorescence anisotropy measurements. | 2007 Jul | 1 |
12 | 14505797 | Stability of the new prodrug 9-aminocamptothecin glucuronide (9ACG) in the presence of human serum albumin. | 2003 Oct 1 | 1 |
13 | 9271208 | Camptothecin-binding site in human serum albumin and protein transformations induced by drug binding. | 1997 Jul 14 | 4 |